Innophos Holdings (Innophos Holdings) Debt-to-Equity : 1.17 (As of Sep. 2019)

View and export this data going back to 2006. Start your Free Trial

What is Innophos Holdings Debt-to-Equity?

Innophos Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2019 was $6.8 Mil. Innophos Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2019 was $389.1 Mil. Innophos Holdings's Total Stockholders Equity for the quarter that ended in Sep. 2019 was $337.9 Mil. Innophos Holdings's debt to equity for the quarter that ended in Sep. 2019 was 1.17.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Innophos Holdings's Debt-to-Equity or its related term are showing as below:

IPHS's Debt-to-Equity is not ranked ^*
in the Chemicals industry.
Industry Median: 0.35
* Ranked among companies with meaningful Debt-to-Equity only.

Innophos Holdings Debt-to-Equity Historical Data

The historical data trend for Innophos Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innophos Holdings Debt-to-Equity Chart

Innophos Holdings Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Debt-to-Equity

Get a 7-Day Free Trial

0.30

0.65

0.54

0.93

0.89

Innophos Holdings Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Debt-to-Equity	Get a 7-Day Free Trial															1.01	0.89	1.11	1.13	1.17

Competitive Comparison of Innophos Holdings's Debt-to-Equity

For the Specialty Chemicals subindustry, Innophos Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innophos Holdings's Debt-to-Equity Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Innophos Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Innophos Holdings's Debt-to-Equity falls into.

Innophos Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Innophos Holdings's Debt to Equity Ratio for the fiscal year that ended in Dec. 2018 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	300)	/	335.515
	=	0.89

Innophos Holdings's Debt to Equity Ratio for the quarter that ended in Sep. 2019 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(6.83	+	389.077)	/	337.898
	=	1.17

Innophos Holdings (NAS:IPHS) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Innophos Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Innophos Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Innophos Holdings (Innophos Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Innophos Holdings Inc (NAS:IPHS) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

259 Prospect Plains Road, Cranbury, NJ, USA, 08512

Website

http://www.innophos.com

Innophos Holdings Inc is a holding company that manufactures and sells through its subsidiaries a variety of ingredients used in the production of food, beverages, dietary supplements, pharmaceuticals, and oral care products. Innophos ingredients are made primarily from specialty phosphates. The company organizes itself into three segments namely Food, Health and Nutrition; Industrial Specialties and Other. The Food, Health and Nutrition segment contribute the maximum revenue. The company operates in U.S., Canada, Mexico and other countries.

Executives

John M Steitz	director	ALBEMARLE CORP, 451 FLORIDA ST, BATON ROUGE LA 70801
Kim Ann Mink	director, officer: Chairman, CEO, President	259 PROSPECT PLAINS RD., BLDG A, CRANBURY NJ 08512
Gary A Cappeline	director	50 E RIVERCENTER BLVD, COVINGTON KY 41012
Karen R Osar	director	C/O WESTVACO CORP, ONE HIGH RIDGE PARK, STAMFORD CT 06905
Mark Santangelo	officer: Sr. VP, Mfg, Eng & EH&S	15710 JOHN F. KENNEDY BLVD., SUITE 300 HOUSTON TX 77032
Peter T Thomas	director	1000 LAKESIDE AVENUE, CLEVELAND OH 44114
Hermanus Kieftenbeld	officer: Senior VP and CFO	259 PROSPECT PLAINS RD., BLDG A, CRANBURY NJ 08512
James P. Zallie	director	5 WESTBROOK CORPORATE CENTER, WESTCHESTER IL 60154
Randy Gress	director, officer: CEO	259 PROSPECT PLAINS ROAD, P O BOX 8000, CRANBURY NJ 08512-8000
Stephen M Zide	director	BAIN CAPITAL PARTNERS, JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Richard Heyse	officer: VP-Chief Financial Officer	259 PROSPECT PLAINS ROAD, BUILDING G, P O BOX 8000, CRANBURY NJ 08512-8000
Bain Capital Investors Llc	10 percent owner	200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Partners Vii Lp	10 percent owner	JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Fund Vii Llc	10 percent owner	JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Fund Vii Lp	10 percent owner	JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116